[144] Gilead Sciences Inc SEC Filing

Rhea-AI Filing Summary

Gilead Sciences insider notice for proposed Rule 144 sale. The filing reports a proposed sale of 28,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $3,318,924.65 and the company’s outstanding shares listed as 1,240,806,916. The filer shows recent acquisitions including a 25,000-share stock option exercise dated 08/15/2025, 2,394 performance shares (01/31/2024) and 606 restricted shares (12/10/2023). The form also lists multiple dispositions by Johanna Mercier in the past three months, with individual sales and gross proceeds disclosed for each trade.

Positive

• Clear Rule 144 disclosure: filing specifies broker, share count and aggregate market value for the proposed sale
• Detailed acquisition history: includes dates and types (stock option exercise, performance shares, restricted stock)
• Recent sales documented: multiple dispositions in the past three months with gross proceeds listed

Negative

• Insider liquidity event: proposed sale equals $3.32 million, which may be viewed negatively by some investors
• Multiple recent disposals: repeated sales by the same holder over the past three months could raise investor scrutiny

Insights

Securities Analyst

TL;DR: Insider has filed to sell a meaningful block of shares, disclosed recent grants and multiple recent sales.

The notice transparently discloses a proposed sale of 28,000 shares valued at $3.32 million via Morgan Stanley Smith Barney and enumerates recent acquisitions including a same-day stock option exercise of 25,000 shares. For investors, this is a routine Rule 144 disclosure showing an insider liquidity event and prior incremental dispositions over the past three months. The filing contains concrete quantities, dates and gross proceeds for recent sales, enabling verification of insider selling activity without offering commentary on motives.

Corporate Governance Expert

TL;DR: Filing meets Rule 144 disclosure requirements; shows ongoing insider sales and recent equity grants.

The document fulfills required disclosures by identifying the broker, share counts, acquisition methods and recent sales by the holder. Notably, the filer recorded recent equity compensation events (performance shares and restricted stock) along with a sizable option exercise. From a governance perspective, the record of multiple disposals in the prior three months plus a new proposed sale warrants attention to insider selling patterns, but the filing itself is procedural and does not indicate noncompliance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28000	3318924.65	1240806916	08/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Stock Option Exercise	Issuer			25000	08/15/2025	Cash
Common	01/31/2024	Performance Shares	Issuer			2394	01/31/2024	Not Applicable
Common	12/10/2023	Restricted Stock	Issuer			606	12/10/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	07/15/2025	649	72058.47
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	07/15/2025	1474	163658.22
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	07/15/2025	877	97373.31
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	06/16/2025	3000	330510.00
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	05/22/2025	12500	1343961.25
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	05/22/2025	12500	1344037.50
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	05/22/2025	860	92468.23
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	05/22/2025	1458	156765.91
JOHANNA MERCIER 333 Lakeside Drive Foster City CA 94404	Common	05/22/2025	682	73329.46

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for GILD disclose?

The Form 144 discloses a proposed sale of 28,000 Gilead common shares with an aggregate market value of $3,318,924.65 to be executed through Morgan Stanley Smith Barney.

Who is the seller and which broker is handling the sale?

The filing lists sales by Johanna Mercier and the proposed 28,000-share sale is to be handled by Morgan Stanley Smith Barney LLC at 1 New York Plaza, New York.

What recent equity acquisitions by the filer are disclosed?

Acquisitions disclosed include a 25,000-share stock option exercise (08/15/2025), 2,394 performance shares (01/31/2024), and 606 restricted shares (12/10/2023).

Does the filing list prior sales in the past three months?

Yes. The form lists multiple prior sales by Johanna Mercier with dates, amounts and gross proceeds, including sales on 05/22/2025, 06/16/2025, and 07/15/2025.

How many Gilead shares are outstanding according to the filing?

The filing states there are 1,240,806,916 shares outstanding.